Literature DB >> 12656915

MUC1 mucin in urological malignancy.

D P Scholfield1, M S Simms, M C Bishop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12656915     DOI： 10.1046/j.1464-410x.2003.04132.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  7 in total

1.  Altered differentiation and proliferation of prostate epithelium in mice lacking the androgen receptor cofactor p44/WDR77.

Authors:  Shen Gao; Hong Wu; Fen Wang; Zhengxin Wang
Journal:  Endocrinology       Date:  2010-06-02       Impact factor: 4.736

Review 2.  Tecemotide: an antigen-specific cancer immunotherapy.

Authors:  Gregory T Wurz; Chiao-Jung Kao; Michael Wolf; Michael W DeGregorio
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Prognostic significance of mucin expression in urothelial bladder cancer.

Authors:  Slavica Stojnev; Ana Ristic-Petrovic; Ljubinka Jankovic Velickovic; Miljan Krstic; Dragan Bogdanovic; Do Throng Khanh; Ana Ristic; Irena Conic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

4.  Induction of invasive transitional cell bladder carcinoma in immune intact human MUC1 transgenic mice: a model for immunotherapy development.

Authors:  Daniel P Vang; Gregory T Wurz; Stephen M Griffey; Chiao-Jung Kao; Audrey M Gutierrez; Gregory K Hanson; Michael Wolf; Michael W DeGregorio
Journal:  J Vis Exp       Date:  2013-10-30       Impact factor: 1.355

5.  MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study.

Authors:  Okyaz Eminaga; Wei Wei; Sarah J Hawley; Heidi Auman; Lisa F Newcomb; Jeff Simko; Antonio Hurtado-Coll; Dean A Troyer; Peter R Carroll; Martin E Gleave; Daniel W Lin; Peter S Nelson; Ian M Thompson; Lawrence D True; Jesse K McKenney; Ziding Feng; Ladan Fazli; James D Brooks
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

6.  Mucin immunohistochemistry in the diagnosis and mapping of extramammary Paget's disease.

Authors:  R F Smith; B H Stern; A A Smith
Journal:  J Cell Mol Med       Date:  2007-12-10       Impact factor: 5.310

7.  Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways.

Authors:  Xiaodong Sun; Xiaoying Fu; Jie Li; Changsheng Xing; Henry F Frierson; Hao Wu; Xiaokun Ding; Tongzhong Ju; Richard D Cummings; Jin-Tang Dong
Journal:  Neoplasia       Date:  2014-06-14       Impact factor: 5.715
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.